PPAR (Peroxisome Proliferator-Activated Receptors) antagonists are compounds that inhibit the activity of PPARs, which play a pivotal role in regulating glucose and lipid metabolism. By blocking these receptors, PPAR antagonists can impact conditions like obesity, diabetes, and dyslipidemia. Research into these molecules is essential for developing therapies that modulate metabolic pathways.